The Royal College of Obstetricians & Gynaecologists have issued updated guidelines as follows:
1.3: Section updated to provide information on new regulations in England, Wales and Scotland permitting the home-use of mifepristone and misoprostol.
2 (31.3.20) 2.4: Additional information on when to provide a further dose of misoprostol for early medical abortion.
2 (31.3.20) 2.4: Additional information on pain relief options for early medical abortion.
2 (31.3.20) 3: New section – added guidance for managing women with suspected or confirmed COVID-19.
SOURCE: Coronavirus (COVID-19) infection and abortion care, Version 2, RCOG, 1 April 2020